跳转至内容
Merck
CN

主要文件

查看所有文档

W372609

DL-苯丙氨酸

99%, FCC

别名:

(±)-2-氨基-3-苯基丙酸

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
C6H5CH2CH(NH2)COOH
化学文摘社编号:
150-30-1
分子量:
165.19
PubChem Substance ID:
24901862
UNSPSC Code:
12164502
Council of Europe no.:
10488
FEMA Number:
3726
Flavis number:
17.017
EC Number:
205-756-7
MDL number:
MFCD00064225
Beilstein/REAXYS Number:
3198807
Organoleptic:
odorless
Biological source:
synthetic
Food allergen:
no known allergens
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

synthetic

Quality Level

400

reg. compliance

FCC

assay

99%

mp

266-267 °C (dec.) (lit.)

application(s)

flavors and fragrances

documentation

see Safety & Documentation for available documents

food allergen

no known allergens

organoleptic

odorless

SMILES string

NC(Cc1ccccc1)C(O)=O

InChI

1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)

InChI key

COLNVLDHVKWLRT-UHFFFAOYSA-N

Still not finding the right product?

Explore all of our products under DL-苯丙氨酸

存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
MKCH8968
MKBT5622V
MKBG7242V
MKBF9207V
59296MH

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Imre W K Kouw et al.
The Journal of clinical endocrinology and metabolism, 100(8), 3103-3111 (2015-06-04)
The progressive loss of muscle mass with aging is accelerated in type 2 diabetes patients. It has been suggested that this is attributed to a blunted muscle protein synthetic response to food intake. The objective of the study was to
Katarzyna M Romek et al.
Proceedings of the National Academy of Sciences of the United States of America, 112(27), 8296-8301 (2015-06-25)
Tramadol, previously only known as a synthetic analgesic, has now been found in the bark and wood of roots of the African medicinal tree Nauclea latifolia. At present, no direct evidence is available as to the biosynthetic pathway of its
Sohei Nakayama et al.
Cancer research, 74(20), 5891-5902 (2014-08-29)
The discovery of somatic mutations in EGFR and development of EGFR tyrosine kinase inhibitors (TKI) have revolutionized treatment for lung cancer. However, resistance to TKIs emerges in almost all patients and currently no effective treatment is available. Here, we show
查看所有相关文献

全球贸易项目编号

货号GTIN
W372609-100G04061834406310
W372609-SAMPLE04061834356790
W372609-1KG04061834406327